Related Experiment Video
Updated: Aug 11, 2025

Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification
Published on: November 20, 2017
Herpud1 deficiency alleviates homocysteine-induced aortic valve calcification
Wenqing Xie1,2, Yue Shan3, Zhuonan Wu4
1Department of Cardiology, Shaoxing People's Hospital, Shaoxing Hospital, Zhejiang University School of Medicine, Shaoxing, 312000, Zhejiang, China.
Insights
Homocysteine (hcy) promotes calcific aortic valve disease (CAVD) by increasing Herpud1 expression via endoplasmic reticulum stress (ERS). Silencing Herpud1 or inhibiting ERS reduces CAVD progression, offering a potential therapeutic strategy.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Cellular Pathophysiology
Background:
- Calcific aortic valve disease (CAVD) has high morbidity and mortality with limited treatment options.
- Homocysteine (hcy) is implicated in CAVD progression.
- The role of endoplasmic reticulum stress (ERS) and specific proteins in hcy-induced CAVD is not fully understood.
Purpose of the Study:
- To investigate the role of the hcy-inducible ERS protein Herpud1 in hcy-induced CAVD.
- To evaluate Herpud1 as a potential therapeutic target for CAVD.
Main Methods:
- Utilized low-density lipoprotein receptor (LDLR) and Herpud1 double knockout mice fed a high methionine diet (HMD) to study in vivo CAVD.
- Assessed aortic valve calcification, ERS activation, autophagy, and osteogenic differentiation of aortic valve interstitial cells (AVICs).
- Investigated Herpud1's role in hcy-related AVIC osteogenic differentiation in vitro by manipulating Herpud1 expression.
Main Results:
- Herpud1 was highly expressed in calcified human and mouse aortic valves and AVICs.
- Hcy increased Herpud1 expression via ERS, promoting CAVD; Herpud1 deficiency inhibited hcy-induced CAVD.
- Herpud1 silencing activated autophagy, inhibiting hcy-induced AVIC osteogenic differentiation; ERS inhibition (4-PBA) reduced aortic valve calcification.
Conclusions:
- Herpud1 is upregulated in hcy-related CAVD through the ERS pathway.
- Herpud1 deficiency or inhibition mitigates hcy-induced CAVD progression.
- Herpud1 silencing or inhibition represents a promising therapeutic strategy for CAVD.
Objectives:
To evaluate the role and therapeutic value of homocysteine (hcy)-inducible endoplasmic reticulum stress (ERS) protein with ubiquitin like domain 1 (Herpud1) in hcy-induced calcific aortic valve disease (CAVD).
Background:
The morbidity and mortality rates of calcific aortic valve disease (CAVD) remain high while treatment options are limited.
Methods:
In vivo, we use the low-density lipoprotein receptor (LDLR) and Herpud1 double knockout (LDLR-/-/Herpud1-/-) mice and used high methionine diet (HMD) to assess of aortic valve calcification lesions, ERS activation, autophagy, and osteogenic differentiation of aortic valve interstitial cells (AVICs). In vitro, the role of Herpud1 in the Hcy-related osteogenic differentiation of AVICs was investigated by manipulating of Herpud1 expression.
Results:
Herpud1 was highly expressed in calcified human and mouse aortic valves as well as primary aortic valve interstitial cells (AVICs). Hcy increased Herpud1 expression through the ERS pathway and promoted CAVD progression. Herpud1 deficiency inhibited hcy-induced CAVD in vitro and in vivo. Herpud1 silencing activated cell autophagy, which subsequently inhibited hcy-induced osteogenic differentiation of AVICs. ERS inhibitor 4-phenyl butyric acid (4-PBA) significantly attenuated aortic valve calcification in HMD-fed low-density lipoprotein receptor-/- (LDLR-/-) mice by suppressing ERS and subsequent Herpud1 biosynthesis.
Conclusions:
These findings identify a previously unknown mechanism of Herpud1 upregulation in Hcy-related CAVD, suggesting that Herpud1 silencing or inhibition is a viable therapeutic strategy for arresting CAVD progression.
Highlights:
• Herpud1 is upregulated in the leaflets of Hcy-treated mice and patients with CAVD. • In mice, global knockout of Herpud1 alleviates aortic valve calcification and Herpud1 silencing activates cell autophagy, inhibiting osteogenic differentiation of AVICs induced by Hcy. • 4-PBA suppressed Herpud1 expression to alleviate AVIC calcification in Hcy treated AVICs and to mitigate aortic valve calcification in mice.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Mitral Stenosis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation I: Introduction
Mitral Valve Prolapse I: Introduction

